Comparison of FRETS-VWF73 to full-length VWF as a substrate for ADAMTS13 activity measurement in human plasma samples

Reza Mahdian; Julie Rayes; Jean-Pierre Girma; Anne Houllier; Bernadette Obert; Dominique Meyer; Agnès Veyradier

doi:10.1160/TH06-03-0166

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2006; 95(06): 1049-1051
DOI: 10.1160/TH06-03-0166

Letters to the Editor

Schattauer GmbH

Comparison of FRETS-VWF73 to full-length VWF as a substrate for ADAMTS13 activity measurement in human plasma samples

Reza Mahdian

¹INSERM U770, Le Kremlin-Bicêtre et Faculté de Médecine de Bicêtre, Université Paris 11, Le Kremlin- Bicêtre, France

,

Julie Rayes

¹INSERM U770, Le Kremlin-Bicêtre et Faculté de Médecine de Bicêtre, Université Paris 11, Le Kremlin- Bicêtre, France

,

Jean-Pierre Girma

¹INSERM U770, Le Kremlin-Bicêtre et Faculté de Médecine de Bicêtre, Université Paris 11, Le Kremlin- Bicêtre, France

,

Anne Houllier

¹INSERM U770, Le Kremlin-Bicêtre et Faculté de Médecine de Bicêtre, Université Paris 11, Le Kremlin- Bicêtre, France

,

Bernadette Obert

¹INSERM U770, Le Kremlin-Bicêtre et Faculté de Médecine de Bicêtre, Université Paris 11, Le Kremlin- Bicêtre, France

,

Dominique Meyer

¹INSERM U770, Le Kremlin-Bicêtre et Faculté de Médecine de Bicêtre, Université Paris 11, Le Kremlin- Bicêtre, France

,

Agnès Veyradier

¹INSERM U770, Le Kremlin-Bicêtre et Faculté de Médecine de Bicêtre, Université Paris 11, Le Kremlin- Bicêtre, France

› Author Affiliations

Abstract

Full Text

References

References
1 Moake JL, Rudy CK, Troll JH. et al. Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med 1982; 307: 1432-5.
2 Plaimauer B, Zimmermann K, Volkel D. et al. Cloning, expression, and functional characterization of the von Willebrand factor-cleaving protease (ADAMTS13). Blood 2002; 100: 3626-32.
3 Levy GG, Nichols WC, Lian EC. et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 2001; 413: 488-94.
4 Furlan M, Robles R, Galbusera M. et al. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 1998; 339: 1578-84.
5 Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998; 339: 1585-94.
6 Kokame K, Matsumoto M, Fujimura Y. et al. VWF73,a region from D1596 to R1668 of von Willebrand factor, provides a minimal substrate for ADAMTS-13. Blood 2004; 103: 607-12.
7 Kokame K, Nobe Y, Kokubo Y. et al. FRETSVWF73, a first fluorogenic substrate for ADAMTS13 assay. Br J Haematol 2005; 129: 93-100.
8 Groot E, Hulstein JJ, Rison CN. et al. FRETSVWF73: a rapid and predictive tool for thrombotic thrombocytopenic purpura. J Thromb Haemost 2006; 04: 698-9.
9 Obert B, Tout H, Veyradier A. et al. Estimation of the von Willebrand factor-cleaving protease in plasma using monoclonal antibodies to vWF. Thromb Haemost 1999; 82: 1382-5.
10 George JN. ADAMTS13, thrombotic thrombocytopenic purpura, and hemolytic uremic syndrome. Curr Hematol Rep 2005; 04: 167-9.
11 Sadler JE, Moake JL, Miyata T. et al. Recent advances in thrombotic thrombocytopenic purpura. Hematology 2004; (Am Soc Hematol Educ Program) 407-23.